CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation ; volume:59 ; number:1 ; day:19 ; month:10 ; year:2023 ; pages:138-140 ; date:1.2024
Bone marrow transplantation ; 59, Heft 1 (19.10.2023), 138-140, 1.2024
- Creator
-
Malagola, Michele
Radici, Vera
Farina, Mirko
Pellizzeri, Simone
Spoldi, Filippo
Morello, Enrico
Polverelli, Nicola
Buttini, Eugenia Accorsi
Bernardi, Simona
Re, Federica
Leoni, Alessandro
Signorini, Liana
Caruso, Arnaldo
Russo, Domenico
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41409-023-02124-y
- URN
-
urn:nbn:de:101:1-2024032510340359820827
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Malagola, Michele
- Radici, Vera
- Farina, Mirko
- Pellizzeri, Simone
- Spoldi, Filippo
- Morello, Enrico
- Polverelli, Nicola
- Buttini, Eugenia Accorsi
- Bernardi, Simona
- Re, Federica
- Leoni, Alessandro
- Signorini, Liana
- Caruso, Arnaldo
- Russo, Domenico
- SpringerLink (Online service)
Other Objects (12)
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation
High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation
Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients
Cytomegalievirus (CMV)-Primärinfektion und kongenitale CMV (cCMV)-Infektion in Sachsen-Anhalt
Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation
High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation
Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients
Cytomegalievirus (CMV)-Primärinfektion und kongenitale CMV (cCMV)-Infektion in Sachsen-Anhalt
Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation
High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation
High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation
Highly immunosuppressive myeloid cells correlate with early relapse after allogeneic stem cell transplantation
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients
Cytomegalievirus (CMV)-Primärinfektion und kongenitale CMV (cCMV)-Infektion in Sachsen-Anhalt
Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation